Asenapine citrate
Based on 2 publication(s) in Google Scholar
Asenapine citrate, an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine citrate can be used in the research of schizophrenia and bipolar disorder.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 1411867-74-7
- 화학식: C23H24ClNO8
- 분자량:477.89
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- 순도&문서
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Asenapine citrate
MoreAll 5-HT Receptor Isoforms
MoreAll Dopamine Receptor Isoforms
MoreAll Adrenergic Receptor Isoforms
MoreAll Histamine Receptor Isoforms
More
Biological Activity
제품 설명
IC50 & Target
|
5-HT1B Receptor 8.4 (pKi) |
5-HT1A Receptor 8.6 (pKi) |
5-HT5 Receptor 8.8 (pKi) |
5-HT6 Receptor 9.6 (pKi) |
5-HT2B Receptor 9.8 (pKi) |
5-HT7 Receptor 9.9 (pKi) |
5-HT2A Receptor 10.2 (pKi) |
5-HT2C Receptor 10.5 (pKi) |
α1-adrenergic receptor 8.9 (pKi) |
Alpha-2A adrenergic receptor 8.9 (pKi) |
Alpha-2C adrenergic receptor 8.9 (pKi) |
Alpha-2B adrenergic receptor 9.5 (pKi) |
D1 Receptor 8.9 (pKi) |
D2 Receptor 8.9 (pKi) |
D4 Receptor 9.0 (pKi) |
D3 Receptor 9.4 (pKi) |
H2 Receptor 8.2 (pKi) |
H1 Receptor 9.0 (pKi) |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1411867-74-7
-
분자량 477.89
-
화학식 C23H24ClNO8
-
SMILES
ClC1=CC=C2OC3=CC=CC=C3[C@@](C4)([H])[C@](CN4C)([H])C2=C1.O=C(CC(C(O)=O)(O)CC(O)=O)O
-
Synonyms
Org 5222 citrate
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
-
Biomed Pharmacother
Identification of the atypical antipsychotic Asenapine as a direct survivin inhibitor with anticancer properties and sensitizing effects to conventional therapies. [Abstract]2025 Jan:182:117756. PMID: 39693907
순도&문서
References
[1]. M Shahid, et al. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. [Content Brief]
[2]. Olivia Frånberg, et al. Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia. Psychopharmacology (Berl). 2008 Feb;196(3):417-29. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Asenapine citrate Related Classifications
HY-10121B Related Classifications
Powered by Bioz